Recent Quotes
My Watchlist
Indicators
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Balchem Corporation - Common Stock (NQ:BCPC)

162.03 +0.28 (+0.17%)
Streaming Delayed Price Updated: 11:16 AM EDT, May 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Balchem Corporation - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Balchem Corporation Announces Quarterly Conference Call for Third Quarter Financial Results on October 25, 2024
From Balchem Corporation
Via GlobeNewswire
News headline image
Should Quality Investors Include NASDAQ:BCPC in Their Portfolio? ↗
Exploring BALCHEM CORP (NASDAQ:BCPC)'s quality characteristics. 
Via Chartmill
News headline image
Balchem Corporation to Present at the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024
From Balchem Corporation
Via GlobeNewswire
News headline image
Should you consider NASDAQ:BCPC for quality investing? ↗
Reasonable Growth, Debt Levels, and a High ROIC Make BALCHEM CORP (NASDAQ:BCPC) Appealing to Quality Investors. 
Via Chartmill
News headline image
Top 2 Materials Stocks You May Want To Dump This Month ↗
 
Via Benzinga
News headline image
Is BALCHEM CORP (NASDAQ:BCPC) suited for quality investing? ↗
Why Quality Investors May Find BALCHEM CORP (NASDAQ:BCPC) Attractive. 
Via Chartmill
News headline image
Balchem Earnings Preview ↗
 
Via Benzinga
News headline image
BCPC Stock Earnings: Balchem Beats EPS, Misses Revenue for Q2 2024 ↗
BCPC stock results show that Balchem beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Balchem Corporation Reports Second Quarter 2024 Financial Results
From Balchem Corporation
Via GlobeNewswire
News headline image
BCPC Stock Earnings: Balchem Beats EPS, Beats Revenue for Q1 2024 ↗
BCPC stock results show that Balchem beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Balchem Corporation Announces Quarterly Conference Call for Second Quarter Financial Results on July 26, 2024
From Balchem Corporation
Via GlobeNewswire
News headline image
Health Officials Keep Close Eye On Bird Flu As It Infects Cows For The First Time ↗
Avian influenza continues to spread among animals and has infected four dairy workers in the US. Concerns about human-to-human transmission are low. 
Via Benzinga
News headline image
Balchem Corporation to Present at the CJS Securities 24th Annual New Ideas Summer Conference on July 10, 2024
From Balchem Corporation
Via GlobeNewswire
News headline image
Balchem Corporation to Present at the Wells Fargo Industrials Conference on June 12, 2024
From Balchem Corporation
Via GlobeNewswire
News headline image
Balchem Corporation to Attend the Deutsche Bank Global Consumer Conference on June 4, 2024
From Balchem Corporation
Via GlobeNewswire
News headline image
American Airlines To Rally Around 59%? Here Are 10 Top Analyst Forecasts For Monday ↗
 
Via Benzinga
News headline image
Balchem Corporation Reports First Quarter 2024 Financial Results
From Balchem Corporation
Via GlobeNewswire
News headline image
New York Jets Announce Multi-Year Partnership with VitaCholine®
First Professional Sports Partnership for VitaCholine® encompasses rights across regions including the United States and the United Kingdom. 
From Balchem Corporation
Via GlobeNewswire
News headline image
Balchem Corporation to Attend the BMO 19th Annual Global Farm to Market Conference on May 16, 2024
From Balchem Corporation
Via GlobeNewswire
News headline image
Balchem Corporation Releases 2023 Sustainability Report
From Balchem Corporation
Via GlobeNewswire
News headline image
Balchem Corporation Announces Quarterly Conference Call for First Quarter Financial Results on May 3, 2024
From Balchem Corporation
Via GlobeNewswire
News headline image
Tuesday Talk: Still Talk Of The Town - Inflation ↗
Inflation doesn't seem to be moving higher, but its downward trajectory seems to have slowed to a crawl, around 3.2%, which is keeping interest rates higher than anticipated. 
Via Talk Markets
Topics Economy
News headline image
Time To Buy These Top-Rated Basic Materials Stocks Amid An Uptick In Inflationary Data ↗
Markets have remained resilient despite February’s CPI and PPI data coming in hotter than anticipated but it may be time to consider buying several highly ranked basic materials stocks and here are a... 
Via Talk Markets
News headline image
Balchem Corporation to Participate at the BNP Paribas Exane 12th Consumer Ingredients Conference on March 14, 2024
From Balchem Corporation
Via GlobeNewswire
News headline image
Balchem Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
From Balchem Corporation
Via GlobeNewswire
News headline image
Earnings Scheduled For February 16, 2024 ↗
Companies Reporting Before The Bell • Arbor Realty Trust (NYSE:ABR) is expected to report quarterly earnings at $0.44 per share on revenue of $97.65 million. 
Via Benzinga
News headline image
Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter Financial Results on February 16, 2024
From Balchem Corporation
Via GlobeNewswire
News headline image
3 Tantalizing Stocks to Invest in the Future of Food ↗
Food stocks saw a reversal in recent years as markets rejected soy-based alternative meats, but a handful of companies are forging new paths. 
Via InvestorPlace
News headline image
Balchem Corporation Named on Newsweek’s 2024 List of America’s Most Responsible Companies
From Balchem Corporation
Via GlobeNewswire
News headline image
Balchem Corporation Announces Dividend
From Balchem Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>